Argireline

Safety Profile

How It Works

Argireline works by mimicking part of a protein called SNAP-25, which is needed for nerve cells to release the chemical signal (acetylcholine) that tells muscles to contract. By blocking this signaling complex (called the SNARE complex), Argireline partially relaxes the facial muscles that cause expression wrinkles like frown lines and crow's feet. Think of it as jamming a fake key into a lock so the real key cannot fully turn. Unlike Botox, which permanently destroys the protein, argireline's effect is temporary and mild, requiring continuous daily application. In practice, most evidence suggests the topical peptide does not penetrate deeply enough through skin to fully behave like injected Botox.

Studied Dosages

Apply to expression line areas (forehead, crow's feet, glabellar lines).

Studies

Tier 3 -- Multiple small human studies exist (PMID 18498523: N=10; PMID 23417317: N=60 RCT; PMID 28150423: N=24 RCT; NCT01381484: N=70 RCT but results unpublished; PMID 38024099: N=19 split-face), but results are inconsistent.

Legal Status

Cosmetic ingredient; not FDA-approved for any medical indication. No FDA Drugs@FDA entry, no DailyMed labeling, and no FDA FAERS adverse event reports found. Classified as a cosmetic active, not a drug, in the US market. Available over-the-counter in serums and creams (PMID 38376906, PMID 38024099).